Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antimicrobial susceptibility of Bordetella pertussis (Part I).

Literature DB >> 2897337

Antimicrobial susceptibility of Bordetella pertussis (Part I).

Abstract

In this review of the literature data are collected from the more recent studies on the susceptibility of Bordetella pertussis to penicillins, cephalosporins, other beta-lactam antibiotics, aminoglycosides, tetracyclines, erythromycin, josamycin, co-trimoxazole and various other antibiotics. The methods of susceptibility testing of B. pertussis are discussed and suggestions for standardization are made.

Entities: Chemical Species

Mesh：

Substances：
Anti-Bacterial Agents

Year: 1988 PMID： 2897337 DOI： 10.1007/bf01644321

Source DB: PubMed Journal: Infection ISSN： 0300-8126 Impact factor: 3.553

18 in total

Review 1. Treatment and prevention of pertussis by antimicrobial agents (Part II).

Authors: J E Hoppe; A Haug
Journal: Infection Date: 1988 May-Jun Impact factor: 3.553

2. Antimicrobial activity and human pharmacology of amoxicillin.

Authors: H C Neu
Journal: J Infect Dis Date: 1974-06 Impact factor: 5.226

3. Susceptibility of Bordetella pertussis to nine antimicrobial agents.

Authors: J W Bass; F W Crast; J B Kotheimer; I A Mitchell
Journal: Am J Dis Child Date: 1969-03

4. Erythromycin for treatment and prevention of pertussis.

Authors: J W Bass
Journal: Pediatr Infect Dis Date: 1986 Jan-Feb

5. Susceptibility of Bordetella pertussis to cephalosporin derivatives and imipenem.

Authors: R M Bannatyne; R Cheung
Journal: Antimicrob Agents Chemother Date: 1984-10 Impact factor: 5.191

6. Antibiotic susceptibility testing of Bordetella pertussis.

Authors: L H Field; C D Parker
Journal: Am J Clin Pathol Date: 1980-09 Impact factor: 2.493

7. Antimicrobial susceptibility of Bordetella pertussis strains isolated from 1960 to 1981.

Authors: R M Bannatyne; R Cheung
Journal: Antimicrob Agents Chemother Date: 1982-04 Impact factor: 5.191

8. Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.

Authors: G Zackrisson; J E Brorson; B Björnegård; B Trollfors
Journal: J Antimicrob Chemother Date: 1985-05 Impact factor: 5.790

9. Trimethoprim: laboratory and clinical studies.

Authors: J H Darrell; L P Garrod; P M Waterworth
Journal: J Clin Pathol Date: 1968-03 Impact factor: 3.411

10. [Azidocillin: activity in vitro, pharmacokinetics and therapeutic results in whooping cough].

Authors: C Simon; W Junk; V Malerczyk
Journal: Arzneimittelforschung Date: 1976

15 in total

1. Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.

Authors: K A Craig-Mylius; A A Weiss
Journal: Antimicrob Agents Chemother Date: 2000-05 Impact factor: 5.191

Review 2. State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors: J E Hoppe
Journal: Infection Date: 1998 Jul-Aug Impact factor: 3.553

3. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).

Authors: J E Hoppe; A Bryskier
Journal: Antimicrob Agents Chemother Date: 1998-04 Impact factor: 5.191

4. Update of epidemiology, diagnosis, and treatment of pertussis.

Authors: J E Hoppe
Journal: Eur J Clin Microbiol Infect Dis Date: 1996-03 Impact factor: 3.267

5. Comparison of four charcoal media for the isolation of Bordetella pertussis.

Authors: J E Hoppe; J Schwaderer
Journal: J Clin Microbiol Date: 1989-05 Impact factor: 5.948

6. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.

Authors: J E Hoppe; A Eichhorn
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-07 Impact factor: 3.267

7. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.

Authors: J M Bartkus; B A Juni; K Ehresmann; C A Miller; G N Sanden; P K Cassiday; M Saubolle; B Lee; J Long; A R Harrison; J M Besser
Journal: J Clin Microbiol Date: 2003-03 Impact factor: 5.948

8. Treatment of pertussis with josamycin.

Authors: D Torre
Journal: Infection Date: 1988 Impact factor: 3.553

Review 9. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors: Seema Mattoo; James D Cherry
Journal: Clin Microbiol Rev Date: 2005-04 Impact factor: 26.132

10. Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis.

Authors: J E Hoppe; T Tschirner
Journal: Eur J Clin Microbiol Infect Dis Date: 1995-09 Impact factor: 3.267